Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 -9.864M
June 30, 2025 -0.0001M
March 31, 2025 -0.0005M
December 31, 2024 -14.90M
September 30, 2024 -0.0017M
June 30, 2024 -0.0446M
March 31, 2024 -0.0491M
December 31, 2023 -0.0051M
September 30, 2023 -0.4793M
June 30, 2023 -0.0007M
March 31, 2023 -0.62M
December 31, 2022 -0.1386M
September 30, 2022 0.00
June 30, 2022 -0.0636M
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.1007M
March 31, 2021 -52.66M
December 31, 2020 -4.00M
September 30, 2020 -2.186M
June 30, 2020 0.00
Date Value
March 31, 2020 -0.55M
December 31, 2019 0.00
September 30, 2019 -0.7534M
June 30, 2019 0.00
March 31, 2019 -0.0631M
December 31, 2018 -63.76M
September 30, 2018 -0.0831M
June 30, 2018 -7.381M
March 31, 2018 -0.0181M
December 31, 2017 0.00
September 30, 2017 0.3295M
June 30, 2017 -6.047M
March 31, 2017 0.00
December 31, 2016 -0.0181M
September 30, 2016 -7.814M
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 -1.340M
September 30, 2015 -4.646M
June 30, 2015 -2.465M
March 31, 2015 -2.326M
December 31, 2014 0.22M
September 30, 2014 -1.514M
June 30, 2014 -0.165M
March 31, 2014 -0.418M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Krystal Biotech, Inc. -15.16M
Ironwood Pharmaceuticals, Inc. -0.303M
SELLAS Life Sciences Group, Inc. -38.83M
Rezolute, Inc. -0.747M
ADMA Biologics, Inc. 25.02M